Literature DB >> 15259461

Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37.

N D Karunaweera1, F Pratlong, H V Y D Siriwardane, R L Ihalamulla, J P Dedet.   

Abstract

Sri Lankan cutaneous leishmaniasis (CL), once considered sporadic, is fairly widespread in some parts of the country. Identification of 5 isolates from 4 CL patients by enzyme analysis during 2002 showed that they were all Leishmania donovani zymodeme MON-37, the parasite which also causes visceral leishmaniasis in India and East Africa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15259461     DOI: 10.1016/s0035-9203(03)90061-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  62 in total

1.  CHARACTERISTICS OF PHLEBOTOMINE SANDFLIES IN SELECTED AREAS OF SRI LANKA.

Authors:  S A S C Senanayake; W Abeyewicreme; E M Dotson
Journal:  Southeast Asian J Trop Med Public Health       Date:  2015-11       Impact factor: 0.267

2.  Diagnosing Cutaneous leishmaniasis using Fluorescence in Situ Hybridization: the Sri Lankan Perspective.

Authors:  Thilini Dilhara Jayasena Kaluarachchi; Manjula Manoji Weerasekera; Andrew J McBain; Shalindra Ranasinghe; Renu Wickremasinghe; Surangi Yasawardene; Nisal Jayanetti; Rajitha Wickremasinghe
Journal:  Pathog Glob Health       Date:  2019-08-20       Impact factor: 2.894

3.  Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method.

Authors:  Supriya Khanra; Subir K Bandopadhyay; Priyanka Chakraborty; Sanchita Datta; Dinesh Mondal; Mitali Chatterjee; Khudiram Naskar; Syamal Roy; Madhumita Manna
Journal:  J Parasit Dis       Date:  2011-06-24

4.  Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.

Authors:  H V Y D Siriwardana; P Karunanayake; L Goonerathne; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2017-08-18       Impact factor: 2.894

5.  Efficacy, Safety and Cost-Effectiveness of Thermotherapy in the Treatment of Leishmania donovani-Induced Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial.

Authors:  Wardha F Refai; Nayani P Madarasingha; Buthsiri Sumanasena; Sudath Weerasingha; Amala De Silva; Rohini Fernandopulle; Abhay R Satoskar; Nadira D Karunaweera
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

6.  Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.

Authors:  Kayoko Waki; Sujoy Dutta; Debalina Ray; Bala Krishna Kolli; Leyla Akman; Shin-Ichiro Kawazu; Chung-Ping Lin; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2006-12-01

7.  Leishmaniases and the Cyprus paradox.

Authors:  Apostolos Mazeris; Ketty Soteriadou; Jean Pierre Dedet; Christos Haralambous; Andreas Tsatsaris; Joanna Moschandreas; Ippokratis Messaritakis; Vasiliki Christodoulou; Byron Papadopoulos; Vladimir Ivovic; Francine Pratlong; Fedias Loucaides; Maria Antoniou
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

8.  Molecular characterization of Leishmania species isolated from cutaneous leishmaniasis in Yemen.

Authors:  Mohammed A K Mahdy; Hesham M Al-Mekhlafi; Abdulsalam M Al-Mekhlafi; Yvonne A L Lim; Naemah O M Bin Shuaib; Ahmed A Azazy; Rohela Mahmud
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

9.  Cross-sectional study to assess risk factors for leishmaniasis in an endemic region in Sri Lanka.

Authors:  Shalindra Ranasinghe; Rajitha Wickremasinghe; Asoka Munasinghe; Sanjeeva Hulangamuwa; Sundaramoorthy Sivanantharajah; Kamal Seneviratne; Samantha Bandara; Indira Athauda; Chaturi Navaratne; Ositha Silva; Hasini Wackwella; Greg Matlashewski; Renu Wickremasinghe
Journal:  Am J Trop Med Hyg       Date:  2013-08-05       Impact factor: 2.345

10.  Cutaneous leishmaniasis, Sri Lanka.

Authors:  Sujeevi S K Nawaratna; Danister J Weilgama; Chandana J Wijekoon; Manel Dissanayake; Kosala Rajapaksha
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.